View in EDS

Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine.

Saved in:
Bibliographic Details
Title: Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine.
Authors: Ring BJ; Department of Drug Disposition, Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana, USA. ring_barbara_j@lilly.com, Eckstein JA, Gillespie JS, Binkley SN, VandenBranden M, Wrighton SA
Source: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2001 Jun; Vol. 297 (3), pp. 1044-50.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print Cited Medium: Print ISSN: 0022-3565 (Print) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 11356927
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ring+BJ%22">Ring BJ</searchLink>; Department of Drug Disposition, Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana, USA. ring_barbara_j@lilly.com<br /><searchLink fieldCode="AU" term="%22Eckstein+JA%22">Eckstein JA</searchLink><br /><searchLink fieldCode="AU" term="%22Gillespie+JS%22">Gillespie JS</searchLink><br /><searchLink fieldCode="AU" term="%22Binkley+SN%22">Binkley SN</searchLink><br /><searchLink fieldCode="AU" term="%22VandenBranden+M%22">VandenBranden M</searchLink><br /><searchLink fieldCode="AU" term="%22Wrighton+SA%22">Wrighton SA</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220376362%22">The Journal of pharmacology and experimental therapeutics</searchLink> [J Pharmacol Exp Ther] 2001 Jun; Vol. 297 (3), pp. 1044-50.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0376362 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0022-3565 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223565%22">00223565 </searchLink><i>NLM ISO Abbreviation: </i>J Pharmacol Exp Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=11356927
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1044
    Titles:
      – TitleFull: Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ring BJ
      – PersonEntity:
          Name:
            NameFull: Eckstein JA
      – PersonEntity:
          Name:
            NameFull: Gillespie JS
      – PersonEntity:
          Name:
            NameFull: Binkley SN
      – PersonEntity:
          Name:
            NameFull: VandenBranden M
      – PersonEntity:
          Name:
            NameFull: Wrighton SA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2001 Jun
              Type: published
              Y: 2001
          Identifiers:
            – Type: issn-print
              Value: 0022-3565
          Numbering:
            – Type: volume
              Value: 297
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: The Journal of pharmacology and experimental therapeutics
              Type: main
ResultId 1